Brind.

ImmuneOnco Biopharmaceuticals conducted clinical trials in China in July 2025.

1 report, 1 independent Updated Jul 31

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

China

How it developed

Newest first. Tap a step to see who reported it.

Jun 10A university in the Far East collaborated on the Chinese translation of clinical trials.Sub-event
Jul 31ImmuneOnco started clinical trials in China.1 source
- GlobeNewswire

Keep exploring

The entities involved

China
cultural region, ancient civilization, and nation in East Asia; mostly refers to the People's Republic of China in political situation and rarely refers to the Republic of China
- The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49
- The Middle Corridor, linking Central Asia and Europe, is gaining significance in regional trade and energy routes.Mon 17:06

Coverage

Newest first; wire copies grouped

Jul 31GlobeNewswireImmuneOnco Announced Preliminary Safety & Efficacy Data from the Clinical Trial Studying IMM2510/AXN-2510, a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in Front-line NSCLC in Chi